MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1973.10%
Quick Ratio
1973.10%
Cash Ratio
1961.94%
Debt to Asset Ratio
5.07%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Other assets, noncurrent
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Preferred stock, value-Series BN...
    • Others

Balance Sheets
2026-06-30
Cash and cash equivalents
540,515
Prepaid expenses and other current assets
3,073
Total current assets
543,588
Other assets, noncurrent
48
Total assets
543,636
Accounts payable
3,482
Accrued expenses and other current liabilities
8,879
Paramora warrant obligation
9,527
Related party accounts payable and other current liabilities
5,662
Total current liabilities
27,550
Other liabilities, noncurrent
27
Total liabilities
27,577
Preferred stock, value-Series BNon Voting Convertible Preferred Stock
117,621
Preferred stock, value-Series CNon Voting Convertible Preferred Stock
12,376
Common stock, par value of 0.00001 per share 500,000,000 shares authorized at june 30, 2026 and 300,000,000 shares authorized at december 31, 2025 61,734,601 and 1,597,321 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
1
Additional paid-in capital
931,649
Accumulated deficit
-546,320
Accumulated other comprehensive income
732
Total stockholders equity
516,059
Total liabilities and stockholders equity
543,636
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$540,515K Prepaid expenses andother current assets$3,073K Total current assets$543,588K Other assets,noncurrent$48K Total assets$543,636K Total liabilities andstockholders equity$543,636K Total stockholdersequity$516,059K Total liabilities$27,577K Accumulated deficit-$546,320K Additional paid-in capital$931,649K Total currentliabilities$27,550K Other liabilities,noncurrent$27K Preferred stock,value-Series BNon Voting...$117,621K Preferred stock,value-Series CNon Voting...$12,376K Accumulated othercomprehensive income$732K Common stock, par valueof 0.00001 per...$1K Paramora warrantobligation$9,527K Accrued expenses andother current...$8,879K Related party accountspayable and other...$5,662K Accounts payable$3,482K

Damora Therapeutics, Inc. (DMRA)

Damora Therapeutics, Inc. (DMRA)